InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,891.91
(
0.16%
)
Post# of 54032
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BAE44

Send PM Follow Ignore
Followers 0
Posts 15
Boards Moderated 0
Alias Born 03/25/2020

BAE44

Re: Johnny_C post# 49067

Wednesday, 03/25/2020 1:13:19 PM

Wednesday, March 25, 2020 1:13:19 PM

Post# of 54032
That's my point - the safety of CBD can be referenced by Epidiolex data. Botanical drug approval exists to deliver patients with efficacious products with non-synthetic API's from natural sources. Fewer and less rigorous clinicals translate to a faster, lower cost approval pathway. Not zero risk, but less risk than the traditional drug pathway.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up